Upcoming Presentation at the Emerging Growth Conference
22nd Century Group, Inc. (Nasdaq: XXII) is making headlines once again as they gear up for participation in the Emerging Growth Virtual Investor Conference. Taking place on a Wednesday, the CEO, Larry Firestone, is set to deliver an insightful presentation at 3:55 PM Eastern Time. This conference is distinguished for showcasing innovative and emerging companies, making it an ideal platform for 22nd Century Group to share their pioneering efforts in tobacco harm reduction.
Engaging with Investors
For those interested in attending, registration is available online. Investors are encouraged to not only join but to engage by submitting questions ahead of time. This interactive aspect enhances the experience, providing an opportunity to connect and understand more about the company’s vision and advancements in the field of nicotine reduction. The chance to interact with the leadership team can spark informative discussions that can benefit all parties involved.
Accessing Previous Content
If you are unable to attend the live session, no worries! An archived version of the presentation will be accessible on the company’s Investor Relations website shortly after the event. This means you won’t miss out on the valuable content that will be shared during the conference.
About 22nd Century Group
22nd Century Group is at the forefront of the tobacco harm reduction movement, dedicated to helping smokers take control of their nicotine consumption. For over 27 years, this innovative company has been leading efforts against the harms of smoking driven by nicotine addiction. Their proprietary technologies focus on developing non-GMO reduced nicotine tobacco plants, which contain up to 95% less nicotine than conventional tobacco. This commitment to reducing nicotine exposure is not just a product line; it’s an entire movement aimed at safety and sustainability in smoking.
Revolutionary Technology in Tobacco Production
The company boasts an extensive patent portfolio that supports its technologies, ensuring that its unique tobacco can be grown commercially at scale. This technological innovation showcases 22nd Century Group’s capability to contribute significantly to public health initiatives and the tobacco industry while maintaining a robust regulatory adherence.
Introducing VLN® Cigarettes
One of 22nd Century Group’s flagship offerings is the VLN® cigarette. Designed specifically for those seeking a familiar smoking experience while aiming to reduce nicotine intake, these cigarettes present an effective alternative. With 95% less nicotine than traditional cigarettes, VLN® has been rigorously tested and shown to significantly lower nicotine consumption for users, marking a substantial progression in tobacco harm reduction strategies.
FDA Authorization of VLN®
Notably, the VLN® cigarette holds the distinction of being the only low nicotine combustible cigarette approved by the FDA in the United States. This seal of approval illustrates both safety and efficacy, amplifying the product's credibility in the market. As such, it marks a pivotal point for smokers who are looking to adjust their habits while remaining within the context of traditional smoking formats.
Engaging with 22nd Century Group
For additional information, stakeholders and interested parties can explore the company’s updating news releases and events via their official website. Engaging through social media platforms also allows for a more dynamic interaction as 22nd Century Group continues to evolve and grow within the industry.
Frequently Asked Questions
What is the purpose of the Emerging Growth Conference?
The Emerging Growth Conference allows innovative companies to present their business models and connect directly with investors.
Who is presenting for 22nd Century Group?
Larry Firestone, the Chief Executive Officer, will be delivering the presentation.
How can investors participate in the conference?
Investors can register online and submit questions ahead of time to engage during the event.
What is the significance of VLN® cigarettes?
VLN® cigarettes are designed to contain 95% less nicotine than traditional cigarettes, offering a safer option for smokers.
Is the VLN® cigarette FDA authorized?
Yes, the VLN® cigarette is the only low nicotine combustible cigarette authorized by the FDA in the U.S.
